Influenza Hemagglutinin (HA) Peptide: Benchmark Epitope Tag for Protein Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a nine-amino acid synthetic tag derived from human influenza hemagglutinin protein, used extensively for protein tagging and detection in molecular biology (https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html). It exhibits high purity (>98%) and stable solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) at room temperature. The HA tag facilitates competitive binding to anti-HA antibodies, enabling efficient immunoprecipitation and elution of HA-tagged fusion proteins (Dong et al., 2025, https://doi.org/10.1002/advs.202504704). APExBIO supplies this peptide under SKU A6004, supporting advanced workflows in protein–protein interaction studies. Proper storage at –20°C (desiccated) preserves activity for research-grade applications.

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide serves as a universal epitope tag for recombinant protein labeling. Its nine-amino acid sequence (YPYDVPDYA) is derived from the surface glycoprotein of the influenza virus, ensuring immunogenicity and antibody specificity (Dong et al., 2025, DOI). This tag enables selective detection and isolation of fusion proteins without altering their biochemical properties. The HA tag is recognized by a wide array of commercial anti-HA antibodies and is compatible with various host expression systems, including mammalian, yeast, and bacterial models. Use of the HA tag supports reproducible analysis of protein–protein interactions, enzymatic modifications, and post-translational dynamics. Its adoption facilitates standardized workflows and data comparability across laboratories (Epitope Peptide 2023), extending beyond conventional detection tags by supporting advanced mechanistic studies involving the ubiquitin pathway and post-translational regulation (KU-0060648 2023).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide operates via competitive binding to anti-HA antibodies. When a fusion protein carrying the HA tag is present in a lysate, it is selectively captured by immobilized anti-HA antibodies on beads or matrices. During competitive elution, excess synthetic HA peptide (YPYDVPDYA) is introduced, outcompeting the fusion protein for antibody binding sites and releasing the HA-tagged protein into solution (APExBIO A6004). This mechanism allows for gentle, non-denaturing recovery of functional protein complexes, preserving their native conformation and interaction partners. The high affinity and specificity of antibodies for the HA epitope underpin the robustness of this approach in immunoprecipitation, western blotting, and affinity purification. The HA tag's defined sequence and lack of predicted secondary structure minimize off-target effects and steric hindrance, supporting its utility in dynamic protein–protein interaction studies (Flag Peptide 2023).

Evidence & Benchmarks

• HA peptide (sequence: YPYDVPDYA) demonstrates >98% purity by HPLC and mass spectrometry (Dong et al., 2025, DOI).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water at 25°C (APExBIO).
• Competitive elution of HA-tagged fusion proteins is effective with 1–5 mM peptide in immunoprecipitation buffers (Dong et al., 2025, DOI).
• HA tag retains antibody specificity across diverse expression systems, with no reported cross-reactivity in mammalian, yeast, or bacterial lysates (Epitope Peptide 2023).
• Use of the HA peptide enables recovery of native protein complexes suitable for downstream enzymatic or mass spectrometric analysis (5-HME-CTP 2023).
• Long-term peptide solution storage at room temperature leads to loss of function, whereas desiccated storage at –20°C maintains stability for ≥12 months (APExBIO).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely applied in:

• Protein–protein interaction analysis using immunoprecipitation and pull-down assays.
• Competitive elution of HA-tagged fusion proteins from anti-HA antibody matrices.
• Affinity purification for preparative or analytical workflows.
• Detection of tagged proteins in western blot, ELISA, and immunofluorescence.
• Mapping the interactome of proteins involved in the ubiquitin pathway (KU-0060648 2023; contrasts with this article by emphasizing dynamic network analysis rather than peptide chemistry).

The current article extends previous reviews by providing explicit purity, solubility, and performance benchmarks for research-grade HA peptide, supporting reproducible and quantitative workflows. For a focus on mechanistic insights and advanced detection strategies, see Amino-11-dUTP 2023 (contrasts by focusing on competitive elution mechanism rather than complete workflow integration).

Common Pitfalls or Misconceptions

• HA peptide does not function as an enzymatic substrate or inhibitor; it solely acts as a competitive epitope for antibody binding.
• The peptide sequence (YPYDVPDYA) must match the tag on the fusion protein; sequence variants may abolish binding or elution efficacy.
• Excess peptide concentration in elution buffers can inhibit downstream enzymatic assays due to competition for antibody sites.
• Long-term storage in solution leads to peptide degradation; always store lyophilized at –20°C.
• HA tag alone does not confer cellular localization or functional activity; it is a detection tag only.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (A6004) integrates into workflows by enabling specific elution of HA-tagged proteins from anti-HA immunoprecipitation matrices. Typical protocols involve incubation of cell lysates (in PBS or Tris buffer, pH 7.4–8.0) with anti-HA magnetic beads, followed by addition of 1–5 mM synthetic HA peptide for competitive elution. High peptide solubility in water, DMSO, and ethanol allows flexibility in buffer formulation. For maximal purity and recovery, maintain peptide solutions at 4°C and use within 24 hours. Do not freeze/thaw working solutions repeatedly. For large-scale protein purification, titrate peptide concentration to match matrix capacity and protein abundance. The peptide is compatible with downstream analytics including mass spectrometry, enzymatic assays, and western blotting. For advanced strategies in protein–protein interaction mapping, see 5-HME-CTP 2023 (extends the present article by exploring HA peptide in context of dynamic ubiquitin signaling studies).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a gold-standard epitope tag for molecular biology applications, combining robust specificity, high purity, and versatile solubility. APExBIO's A6004 product offers validated performance for protein detection, purification, and interaction studies. As mechanistic research on protein ubiquitination and post-translational modification expands, the HA tag will continue to underpin reproducible, high-sensitivity workflows. Future developments may focus on multiplexed epitope tagging and integration with next-generation analytical platforms for systems-level proteomics. For technical specifications and ordering, refer to the Influenza Hemagglutinin (HA) Peptide product page.